Form EFFECT Estrella Immunopharma,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 23, 2026 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Estrella Immunopharma adds fourth site to lymphoma trial
- WANPY® Becomes the First Chinese Pet Food Brand to Receive the WPA International Excellence Award, Earning International Recognition for Its Systematic Capabilities
- Fountain Asset Corp. Announces its Financial Results for the Quarter Ended June 30, 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
